Only 17 pts, but encouraging if their research it good. Any...

Only 17 pts, but encouraging if their research it good.
Any views from radiologists?

My thinking is that if the scan is a good predictor, then it may allow variable post treatment follow up plans to be implemented, and thus concentrating efforts on the risk cases.

Also interested in any view as to the 'radioembolization for liver metastases from pancreatic cancer'. I would have thought that there is little difference to mCRC, but not being a cancer specialist would like comment from anyone who would have an educated view.

It is also interesting that folks with pancreatic cancer have liver mets, and sufficient time to have SIRT and follow up.

My understanding is that for most folks, by the time pancreatic cancer is diagnosed their life expectancy is rather short and will invariably be the cause of death. So I'm perplexed as to why there would be a SIRT treatment for the liver. Any views?
--------------------------------------------------
http://jnm.snmjournals.org/content/...id=1&usestrictdates=yes&resourcetype=HWCIT&ct


PET response criteria (PERCIST) predict progression-free survival and overall survival after radioembolization for liver metastases from pancreatic cancer

Conclusion: Metabolic response by 18F-FDG PET/CT predicts overall survival, progression-free survival and time to intrahepatic progression after radioembolization for liver metastases from pancreatic cancer.